InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Karen Firestone
31 Aug 2026
Director
Exercised, kept
25,000
$5.05
$126.25K
Karen Firestone
31 Aug 2026
Director
Exercised, kept
25,000
$1.76
$44.00K
Justin B. Klee
5 Feb 2025
Co-Chief Executive Officer
Exercised, kept
36,310
$1.57
$57.01K
Justin B. Klee
4 Nov 2024
Co-Chief Executive Officer
Exercised, kept
63,690
$1.57
$99.99K
Joshua B Cohen
23 Sep 2024
Co-Chief Executive Officer
Exercised, kept
1,857
$1.57
$2.92K
Joshua B Cohen
12 Sep 2024
Co-Chief Executive Officer
Exercised, kept
34,449
$1.57
$54.08K
Margaret Olinger
27 Dec 2023
Chief Commercial Officer
Exercised, kept
25,000
$0.37
$9.25K
Joshua B Cohen
16 Nov 2023
Co-Chief Executive Officer
Exercised, kept
63,694
$1.57
$100.00K
James M Frates
23 Aug 2023
Chief Financial Officer
Exercised, kept
18,165
$6.88
$124.98K
Margaret Olinger
12 Jul 2023
Chief Commercial Officer
Exercised, kept
20,000
$0.37
$7.40K
James M Frates
30 Dec 2022
Chief Financial Officer
Exercised, kept
5,000
$6.88
$34.40K
Joshua B Cohen
5 May 2022
Co-Chief Executive Officer
Exercised, kept
334,520
$0.37
$123.77K
Justin B. Klee
5 May 2022
Co-Chief Executive Officer
Exercised, kept
334,520
$0.37
$123.77K
Show all 162 transactions →

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 9
Sales at will 117
Transactions with no price 0
Shares from compensation/vesting 38,287,796
Sales filed before the plan box existed 42
History held since 10 Jan 2022